XML 52 R41.htm IDEA: XBRL DOCUMENT
v3.25.3

Warrants - Schedule of Fair Value Assumptions (Details) | Sep. 30, 2025 year $ / shares | Feb. 18, 2025 year $ / shares | Dec. 31, 2024 year $ / shares
--- | --- | --- | ---
Expected term (years) | Initial OrbiMed Warrant |  |  |
Derivative Instruments and Hedging Activities Disclosures [Line Items] |  |  |
Derivative liability, measurement input | year | 5.6 |  | 6.3
Expected term (years) | Subsequent OrbiMed Warrants |  |  |
Derivative Instruments and Hedging Activities Disclosures [Line Items] |  |  |
Derivative liability, measurement input | year | 6.4 | 7.0 |
Risk-free interest rate | Initial OrbiMed Warrant |  |  |
Derivative Instruments and Hedging Activities Disclosures [Line Items] |  |  |
Derivative liability, measurement input | 0.038 |  | 0.045
Risk-free interest rate | Subsequent OrbiMed Warrants |  |  |
Derivative Instruments and Hedging Activities Disclosures [Line Items] |  |  |
Derivative liability, measurement input | 0.039 | 0.041 |
Expected volatility | Initial OrbiMed Warrant |  |  |
Derivative Instruments and Hedging Activities Disclosures [Line Items] |  |  |
Derivative liability, measurement input | 0.700 |  | 0.700
Expected volatility | Subsequent OrbiMed Warrants |  |  |
Derivative Instruments and Hedging Activities Disclosures [Line Items] |  |  |
Derivative liability, measurement input | 0.700 | 0.700 |
Dividend yield | Initial OrbiMed Warrant |  |  |
Derivative Instruments and Hedging Activities Disclosures [Line Items] |  |  |
Derivative liability, measurement input | 0 |  | 0
Dividend yield | Subsequent OrbiMed Warrants |  |  |
Derivative Instruments and Hedging Activities Disclosures [Line Items] |  |  |
Derivative liability, measurement input | 0 | 0 |
Exercise price | Initial OrbiMed Warrant |  |  |
Derivative Instruments and Hedging Activities Disclosures [Line Items] |  |  |
Derivative liability, measurement input |  |  | 9.3722
Exercise price | Subsequent OrbiMed Warrants |  |  |
Derivative Instruments and Hedging Activities Disclosures [Line Items] |  |  |
Derivative liability, measurement input |  | 5.4787 |
Stock price | Initial OrbiMed Warrant |  |  |
Derivative Instruments and Hedging Activities Disclosures [Line Items] |  |  |
Derivative liability, measurement input | 4.65 |  | 5.01
Stock price | Subsequent OrbiMed Warrants |  |  |
Derivative Instruments and Hedging Activities Disclosures [Line Items] |  |  |
Derivative liability, measurement input | 4.65 | 5.69 |

X
- Definition Warrant Liability, Measurement Input + References No definition available. + Details
Name: | tlsi_WarrantLiabilityMeasurementInput
Namespace Prefix: | tlsi_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4EE -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4EE Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4EE -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4EE Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 181 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480401/815-10-55-181 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4EEE -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4EEE -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4EEE -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4EE -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4EE + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_InitialOrbiMedWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_SubsequentOrbiMedWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |